David Linetsky Phreesia, Inc. (PHR) insider trading activity

PHR Quotes by TradingView

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 188,354 shares of PHR, which is worth approximately $4.74 Million. The most recent transaction as insider was on Dec 11, 2024, when has been sold 11,853 shares (Common Stock) at a price of $24.85 per share, resulting in proceeds of $294,547. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 188K
7.36% 3M change
12.41% 12M change
Total Value Held $4.74 Million

David Linetsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2024
SELL
Open market or private sale
$294,547 $24.85 p/Share
11,853 Reduced 5.92%
188,354 Common Stock
Oct 18 2024
SELL
Open market or private sale
$22,539 $20.49 p/Share
1,100 Reduced 0.55%
200,207 Common Stock
Oct 15 2024
SELL
Open market or private sale
$42,291 $21.03 p/Share
2,011 Reduced 0.99%
201,307 Common Stock
Sep 10 2024
SELL
Open market or private sale
$39,897 $23.25 p/Share
1,716 Reduced 0.84%
203,318 Common Stock
Sep 06 2024
BUY
Grant, award, or other acquisition
-
2,816 Added 1.35%
205,034 Common Stock
Jul 16 2024
SELL
Open market or private sale
$43,206 $23.74 p/Share
1,820 Reduced 0.89%
202,218 Common Stock
Apr 15 2024
SELL
Open market or private sale
$50,566 $22.86 p/Share
2,212 Reduced 1.07%
204,038 Common Stock
Apr 08 2024
SELL
Open market or private sale
$89,317 $22.82 p/Share
3,914 Reduced 1.86%
206,250 Common Stock
Apr 05 2024
BUY
Grant, award, or other acquisition
-
6,105 Added 2.82%
210,164 Common Stock
Jan 17 2024
SELL
Open market or private sale
$739,495 $24.12 p/Share
30,659 Reduced 13.06%
204,059 Common Stock
Jan 16 2024
SELL
Open market or private sale
$56,906 $24.55 p/Share
2,318 Reduced 0.98%
234,718 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
22,000 Added 8.49%
237,036 Common Stock
Oct 16 2023
SELL
Open market or private sale
$34,515 $16.61 p/Share
2,078 Reduced 0.96%
215,036 Common Stock
Sep 13 2023
SELL
Open market or private sale
$42,724 $20.75 p/Share
2,059 Reduced 0.94%
217,114 Common Stock
Sep 12 2023
BUY
Exercise of conversion of derivative security
$68,984 $5.82 p/Share
11,853 Added 5.13%
219,173 Common Stock
Sep 12 2023
BUY
Grant, award, or other acquisition
-
3,279 Added 1.56%
207,320 Common Stock
Jul 14 2023
SELL
Payment of exercise price or tax liability
$65,686 $33.72 p/Share
1,948 Reduced 0.95%
204,041 Common Stock
Apr 14 2023
SELL
Payment of exercise price or tax liability
$61,634 $31.64 p/Share
1,948 Reduced 0.94%
205,989 Common Stock
Apr 10 2023
SELL
Payment of exercise price or tax liability
$54,270 $30.15 p/Share
1,800 Reduced 0.86%
207,937 Common Stock
Apr 10 2023
BUY
Grant, award, or other acquisition
-
4,248 Added 1.99%
209,737 Common Stock
Feb 02 2023
SELL
Open market or private sale
$449,999 $39.55 p/Share
11,378 Reduced 5.25%
205,489 Common Stock
Jan 17 2023
SELL
Payment of exercise price or tax liability
$33,740 $35.0 p/Share
964 Reduced 0.44%
216,867 Common Stock
Jan 15 2023
SELL
Payment of exercise price or tax liability
$398,220 $35.41 p/Share
11,246 Reduced 6.12%
172,647 Common Stock
Jan 15 2023
BUY
Grant, award, or other acquisition
-
45,184 Added 17.18%
217,831 Common Stock
Jan 14 2023
SELL
Payment of exercise price or tax liability
$56,372 $35.41 p/Share
1,592 Reduced 0.86%
183,893 Common Stock
DL

David Linetsky

SVP, Life Sciences
Raleigh, NC

Track Institutional and Insider Activities on PHR

Follow Phreesia, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

News

Receive news related to Phreesia, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHR